TARA logo

Protara Therapeutics (TARA) EBITDA

Annual EBITDA

-$49.15 M
-$5.88 M-13.59%

December 31, 2024


Summary


Performance

TARA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTARAprofitabilitymetrics:

Quarterly EBITDA

-$14.31 M
-$2.07 M-16.87%

December 1, 2024


Summary


Performance

TARA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTARAprofitabilitymetrics:

TTM EBITDA

-$48.90 M
-$3.38 M-7.42%

December 1, 2024


Summary


Performance

TARA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTARAprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

TARA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.6%-30.9%-13.0%
3 y3 years-8.3%-34.8%+31.2%
5 y5 years-529.0%-34.8%+31.2%

TARA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-13.6%+23.9%-94.6%+63.1%-37.5%+31.2%
5 y5-year-529.0%+23.9%-471.8%+63.1%-678.0%+31.2%
alltimeall time-529.0%+23.9%-901.8%+63.1%-3323.0%+31.2%

Protara Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$49.15 M(+13.6%)
-
-
Dec 2024
-
-$14.31 M(+16.9%)
-$48.90 M(+7.4%)
Sep 2024
-
-$12.25 M(+15.8%)
-$45.53 M(+3.7%)
Jun 2024
-
-$10.58 M(-10.1%)
-$43.90 M(-3.3%)
Mar 2024
-
-$11.77 M(+7.6%)
-$45.38 M(+4.9%)
Dec 2023
-$43.27 M(-33.0%)
-$10.93 M(+2.9%)
-$43.27 M(-39.2%)
Sep 2023
-
-$10.62 M(-11.9%)
-$71.12 M(+4.8%)
Jun 2023
-
-$12.06 M(+24.9%)
-$67.86 M(+6.1%)
Mar 2023
-
-$9.65 M(-75.1%)
-$63.93 M(-1.0%)
Dec 2022
-$64.57 M
-$38.78 M(+427.5%)
-$64.57 M(+81.6%)
Sep 2022
-
-$7.35 M(-9.7%)
-$35.55 M(-5.9%)
Jun 2022
-
-$8.14 M(-20.9%)
-$37.80 M(-9.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$10.29 M(+5.3%)
-$41.88 M(-6.4%)
Dec 2021
-$45.40 M(+34.2%)
-$9.77 M(+1.8%)
-$44.74 M(+3.1%)
Sep 2021
-
-$9.60 M(-21.5%)
-$43.40 M(+3.7%)
Jun 2021
-
-$12.22 M(-7.0%)
-$41.84 M(+13.4%)
Mar 2021
-
-$13.15 M(+56.1%)
-$36.88 M(+9.0%)
Dec 2020
-$33.84 M(+333.1%)
-$8.43 M(+4.9%)
-$33.84 M(+21.2%)
Sep 2020
-
-$8.04 M(+10.6%)
-$27.91 M(+25.6%)
Jun 2020
-
-$7.27 M(-28.1%)
-$22.23 M(+35.6%)
Mar 2020
-
-$10.11 M(+303.9%)
-$16.40 M(+160.8%)
Dec 2019
-$7.81 M(-63.2%)
-$2.50 M(+6.3%)
-$6.29 M(+66.2%)
Sep 2019
-
-$2.35 M(+64.8%)
-$3.78 M(+164.8%)
Jun 2019
-
-$1.43 M
-$1.43 M
Dec 2018
-$21.26 M
-
-

FAQ

  • What is Protara Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Protara Therapeutics?
  • What is Protara Therapeutics annual EBITDA year-on-year change?
  • What is Protara Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Protara Therapeutics?
  • What is Protara Therapeutics quarterly EBITDA year-on-year change?
  • What is Protara Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Protara Therapeutics?
  • What is Protara Therapeutics TTM EBITDA year-on-year change?

What is Protara Therapeutics annual EBITDA?

The current annual EBITDA of TARA is -$49.15 M

What is the all time high annual EBITDA for Protara Therapeutics?

Protara Therapeutics all-time high annual EBITDA is -$7.81 M

What is Protara Therapeutics annual EBITDA year-on-year change?

Over the past year, TARA annual EBITDA has changed by -$5.88 M (-13.59%)

What is Protara Therapeutics quarterly EBITDA?

The current quarterly EBITDA of TARA is -$14.31 M

What is the all time high quarterly EBITDA for Protara Therapeutics?

Protara Therapeutics all-time high quarterly EBITDA is -$1.43 M

What is Protara Therapeutics quarterly EBITDA year-on-year change?

Over the past year, TARA quarterly EBITDA has changed by -$3.38 M (-30.89%)

What is Protara Therapeutics TTM EBITDA?

The current TTM EBITDA of TARA is -$48.90 M

What is the all time high TTM EBITDA for Protara Therapeutics?

Protara Therapeutics all-time high TTM EBITDA is -$1.43 M

What is Protara Therapeutics TTM EBITDA year-on-year change?

Over the past year, TARA TTM EBITDA has changed by -$5.63 M (-13.02%)